Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates

Core Insights - Astrana Health, Inc. reported quarterly earnings of $0.01 per share, significantly missing the Zacks Consensus Estimate of $0.47 per share, representing an earnings surprise of -97.87% [1] - The company posted revenues of $956.05 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 0.61%, and showing a substantial increase from $478.71 million year-over-year [2] - Astrana Health, Inc. has not surpassed consensus EPS estimates over the last four quarters, indicating a trend of underperformance in earnings expectations [2] Financial Performance - The earnings for the previous year were $0.33 per share, highlighting a decline in earnings year-over-year [1] - The company has topped consensus revenue estimates three times in the last four quarters, indicating some strength in revenue generation despite the earnings miss [2] - The current consensus EPS estimate for the upcoming quarter is $0.45 on revenues of $978.65 million, and for the current fiscal year, it is $1.24 on revenues of $3.2 billion [7] Market Position - Astrana Health, Inc. shares have increased by approximately 5.4% since the beginning of the year, underperforming compared to the S&P 500's gain of 15.6% [3] - The Zacks Rank for Astrana Health, Inc. is currently 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6] - The Medical - Outpatient and Home Healthcare industry, to which Astrana Health belongs, is currently ranked in the top 19% of over 250 Zacks industries, indicating a favorable industry outlook [8]